Maria Abad Arranz
Overview
Explore the profile of Maria Abad Arranz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hernandez L, Caballero Eraso C, Abad Arranz M, Marquez Martin E, Calero Acuna C, Lopez-Campos J
Arch Bronconeumol (Engl Ed)
. 2022 Jun;
57(9):593-594.
PMID: 35698941
No abstract available.
2.
Hernandez L, Caballero Eraso C, Ruiz-Duque B, Abad Arranz M, Marquez Martin E, Calero Acuna C, et al.
J Clin Med
. 2021 Apr;
10(8).
PMID: 33921051
Chronic obstructive pulmonary disease (COPD) patients constitute a heterogeneous population in terms of treatment response. Our objective was to identify possible predictive factors of response to treatment with single bronchodilation...
3.
Hernandez L, Caballero Eraso C, Ruiz-Duque B, Abad Arranz M, Marquez Martin E, Calero Acuna C, et al.
Arch Bronconeumol
. 2021 Feb;
58(1):30-34.
PMID: 33546927
Objectives: In a clinical phenotype-based management strategy for COPD, it would be preferable to at least assign all patients to a phenotype, but to a single phenotype only. The aim...
4.
Arellano-Orden E, Calero C, Lopez-Ramirez C, Sanchez-Lopez V, Lopez-Villalobos J, Abad Arranz M, et al.
Int J Chron Obstruct Pulmon Dis
. 2019 Aug;
14:1323-1332.
PMID: 31417249
Previous studies have shown that the arterial wall is a potential source of inflammatory markers in COPD. Here, we sought to compare the expression of acute phase reactants (APRs) in...
5.
Lopez-Campos J, Calero-Acuna C, Marquez-Martin E, Gallego E, Carrasco-Hernandez L, Abad Arranz M, et al.
Int J Chron Obstruct Pulmon Dis
. 2017 Jul;
12:1867-1876.
PMID: 28694697
Objective: The combination of a long-acting muscarinic antagonist (LAMA) and a long-acting β-agonist (LABA) in a single inhaler is a viable treatment option for patients with chronic obstructive pulmonary disease...
6.
Lopez-Campos J, Abad Arranz M, Calero-Acuna C, Romero-Valero F, Ayerbe-Garcia R, Hidalgo-Molina A, et al.
Int J Chron Obstruct Pulmon Dis
. 2017 Apr;
12:785-792.
PMID: 28424549
Objectives: Clinical practice in chronic obstructive pulmonary disease (COPD) can be influenced by weather variability throughout the year. To explore the hypothesis of seasonal variability in clinical practice, the present...
7.
Lopez-Campos J, Abad Arranz M, Calero Acuna C, Romero Valero F, Ayerbe Garcia R, Hidalgo Molina A, et al.
Int J Chron Obstruct Pulmon Dis
. 2016 Jun;
11:1171-8.
PMID: 27330285
Introduction: This study is an analysis of a pilot COPD clinical audit that evaluated adherence to guidelines for patients with COPD in a stable disease phase during a routine visit...
8.
Lopez-Campos J, Abad Arranz M, Calero-Acuna C, Romero-Valero F, Ayerbe-Garcia R, Hidalgo-Molina A, et al.
PLoS One
. 2016 Mar;
11(3):e0151896.
PMID: 26985822
Objectives: Previous clinical audits of COPD have provided relevant information about medical intervention in exacerbation admissions. The present study aims to evaluate adherence to current guidelines in COPD through a...
9.
Lopez-Campos J, Abad Arranz M, Calero Acuna C, Romero Valero F, Ayerbe Garcia R, Hidalgo Molina A, et al.
PLoS One
. 2015 Nov;
10(11):e0141856.
PMID: 26544556
Objectives: Previous clinical audits for chronic obstructive pulmonary disease (COPD) have provided valuable information on the clinical care delivered to patients admitted to medical wards because of COPD exacerbations. However,...